Search clinical trials for: Buprenorphine-naloxone

Total 696 results

Indiana University
National Institute on Drug Abuse (NIDA)

Enrolling by invitation

Multimodal Fetal and Placental Imaging and Biomarkers of Clinical Outcomes in Opioid Use Disorder

Substance-Related Disorders | Pregnancy Related | Narcotic-Related Disorders | Opioid Use Disorder | Buprenorphine Dependence | Methadone Dependence

United States
University of California, San Francisco

Completed

Biology and Experience of Eating in Women With Obesity (BEE)

Obesity

United States
Hennepin Healthcare Research Institute
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Recruiting

EXHIT ENTRE Comparative Effectiveness Trial (EXHITENTRE)

Substance Use Disorder | Opioid Use Disorder, Moderate | Opioid Use Disorder, Severe

United States
Medical University of South Carolina

Recruiting

RM1 Project 1 - tAN Naloxone

Analgesia

United States
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

Clinical Study on the Effect of Tizanidine on the Function and Pain of Patients After Shoulder Arthroscopy

Rotator Cuff Tears
RTI International
University of California, San Diego; Heluna Health

Recruiting

Improving Equitable Access to Naloxone to Prevent Opioid Overdose Deaths Within Syringe Service Programs (SAIA-Naloxone) (SAIA-N)

Overdose | Implementation as Usual

United States
USWM, LLC (dba US WorldMeds)

Completed

Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction

Substance Withdrawal Syndrome | Opiate Dependence | Opiate Addiction

United States
Tesaro, Inc.

Completed

Crossover Study to Assess the Relative Bioavailability and Bioequivalence of Niraparib Tablet Compared to Niraparib Capsule

Neoplasms

United States
King's College London
Mundipharma Research Limited

Recruiting

European Cohort Study of the Effectiveness of Take Home Naloxone (NalPORS)

Opioid Overdose

Denmark, United Kingdom, Sweden
University of California, San Diego
National Center for Complementary and Integrative Health (NCCIH)

Completed

Chronic Low Back Pain and Meditation

Pain

United States
Mundipharma Research GmbH & Co KG

Completed

To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain

Non-malignant Pain | Malignant Pain

Germany
Washington University School of Medicine

Completed

Naloxone for Optimizing Hypoxemia Of Lung Donors (NO-HOLDS)

Brain Death | Lung Transplantation | Organ Donors

United States
Salem Anaesthesia Pain Clinic

Recruiting

Kratom Use Disorder Management Using Clonidine and/or Buprenorphine

Withdrawal Syndrome

Canada
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

A Laboratory Model for Heroin Abuse Medications - 8

Substance-Related Disorders | Opioid-Related Disorders | Heroin Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2

Substance-Related Disorders | Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1

Substance Abuse, Intravenous | Opioid-Related Disorders | Heroin Dependence

United States
University of California, Los Angeles

Completed

Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Yale University

Completed

Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Completed

Effects of Buprenorphine and Naloxone in Opiate Addicts - 4

Substance-Related Disorders | Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Clinical Rescue Protocol - 2

Opioid-Related Disorders

United States
Mundipharma Research Limited

Completed

Bioequivalence and Adhesion Comparison of Buprenorphine Patches

Pain

United Kingdom
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dosing Interval - 5

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase IV - 5

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase VI - 7

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Gradual Vs. Rapid Buprenorphine Detoxification - 2

Opioid-Related Disorders

United States
Bausch Health Americas, Inc.

Completed

Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function

Healthy Males

United States
Indivior Inc.

Completed

Buprenorphine-Fentanyl Interaction Study

Healthy | Opioid Use

Netherlands
Aurora Quaye
MaineHealth

Terminated

The Effect of Buprenorphine Continuation for Patients With Opioid Use Disorder

Opioid-use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 2

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 3

Opioid-Related Disorders

United States
Virginia Commonwealth University

Completed

Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal

Drug Overdose | Opioid-use Disorder | Opioid Withdrawal

United States
University of Pittsburgh
National Institutes of Health (NIH); National Center for Research Resources... and other collaborators

Completed

Buprenorphine for Late-Life Treatment Resistant Depression (BUILD)

Depression

United States
National Institute on Drug Abuse (NIDA)
Cincinnati MDRU

Completed

Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Completed

Buprenorphine Maintenance for Opiate Dependence - 6

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Liquid vs. Tablet Buprenorphine - 6

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Mclean Hospital

Completed

Treatment Efficacy for Drug Abuse and AIDS Prevention - 2

Heroin Dependence | Cocaine-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detox With Two Types of Treatment. BBD II - 11

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate-Day Buprenorphine Administration. Phase VIII - 9

Opioid-Related Disorders

United States
Mundipharma Korea Ltd

Completed

An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders (NOBLE)

Spinal Disorder

Korea, Republic of
National Institute on Drug Abuse (NIDA)

Completed

Study Comparing Liquid and Tablet Buprenorphine Formulations - 5

Heroin Dependence

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 21

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase X - 15

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase XII - 17

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detox With Two Types of Treatment. BBD I - 10

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase II - 4

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase VII - 8

Opioid-Related Disorders

United States
Kuopio University Hospital
University of Eastern Finland

Completed

Effects of Low Dose Buprenorphine on Recovery After Hip or Knee Arthroplasty (lonkkalaasta)

Pain | Osteoarthritis

Finland
Purdue Pharma LP

Completed

Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee

Chronic Pain | Osteoarthritis of the Knee

United States
University College Dublin

Completed

The Use of Low Dose Prophylactic Naloxone Infusion to Prevent Respiratory Depression With Intrathecal Morphine. (NAPRESSIM)

Respiratory Depression

Ireland

Search clinical trials for: Buprenorphine-naloxone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations